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found that renal vasoconstriction at the level of the
efferent and afferent arteriole is associated with micro-
albuminuria. They also state that the main haemody-
namic characteristic leading to increased renal
vascular resistance is a rise in blood pressure.
We have similar concerns with regard to the total
antioxidant capacity (TAC) assay. This assay only
measures the chain-breaking antioxidants such as
urate, vitamin C and vitamin E. Whether measure-
ment of chain breaking antioxidants is a reliable
indicator of oxidant stress as a whole remains to be
determined. However, the principal problem with
the TAC assay is its great dependence on plasma
urate level.5 This represents a methodological prob-
lem as during ischaemia-reperfusion events uric acid
is produced as a by-product of hypoxanthine metab-
olism. Therefore, a fall in TAC may reflect decreased
uric acid formation due to less hypoxanthine meta-
bolism (i.e. due to reduced oxidant stress) or, paradox-
ically, consumption of uric acid as an antioxidant (i.e.
due to increased oxidant stress).
Given that markers such as TAC, UACR and vWF
may be affected by factors such as antihypertensive
treatment, degree of diabetic control and smoking sta-
tus, it is important in a very small study such as this to
know whether such parameters changed during the
course of the study. Could the authors, therefore, com-
ment on the time interval between the pre angioplasty
assessment and the post angioplasty assessment
and detail how many of the patients received any
alteration to their antihypertensive treatment or cut-
down/gave-up smoking in this time period?
Could the authors clarify the statistical test used to
determine the statistically significant fall that they
found in TAC after angioplasty. The difference in
TAC from pre to post angioplasty is extremely small,
yet they have shown that it is statistically significant at
the 5 time points measured. Did they correct the p
value appropriately for repeated measures using, for
example, the Bonferroni correction?
E. P. L. Turton and D. J. A. Scott
Dept. of Vascular Surgery,
St. James's University Hospital, Leeds, U.K.
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We read with interest Naylor et al.'s audit of complex
wound and graft infections.1 Graft infections,
although uncommon, remain potentially catastrophic
and any research to improve their prevention and
management is welcome. Whilst this was a very wel-
come study, the strengths of any conclusions were
limited due to a number of weaknesses:
(1) Although the study was multi-centric the number
of centres participating and the proportion of
patients from each centre were not stated. This
introduces additional bias to a study, which from
the outset was subject to reporting bias.
(2) Patients with type II and type III infections were
included in the study as complex wound infec-
tions despite Szilagyi's original paper which states
that grade II infections healed promptly without
significant sequelae. Perhaps only grade III infec-
tions should be considered as complex?2
(3) The definition of graft infection is not included in
the paper other than that the diagnosis was made
on clinical or radiological grounds. Furthermore,
ten patients (13%) with a wound infection had no
microbiology data recorded. These patients should
not have been included in the study as we do not
know if their MRSA status (they appear to have
been included in the MRSA negative group).
(4) The method (simple swab or aspiration), timing
(pre or post antibiotics) and number of woundEur J Vasc Endovasc Surg Vol 23, June 2002
572 Correspondenceswabs taken for microbiology is unclear and
there is no information indicating whether
blood cultures were taken. Finally, in cases where
multiple organisms were cultured it is unclear
which or how many of these were considered
significant.
(5) The patient group is extremely heterogeneous
and includes patients with wound infections
following procedures as diverse as carotid endar-
terectomy, aortic reconstruction and infra-inguinal
bypass. Previous studies have shown that
these patients display different patterns of infec-
tion and are susceptible to different micro-
organisms.2
(6) Table 1 includes various details relating to sur-
gical, patient and surgeon factors and the pre-
operative MRSA status. Whilst of potential
interest and extremely useful, similar data for a
control group (patients without infection), is not
presented. In particular, 15% of patients with
infection were not given peri-operative antibiotics
but there is no comparison with controls.
(7) MRSA positive patients were noted to have sig-
nificantly longer hospital stays in both groups.
This may be related to severity of infection but
could also be due to other factors such as lack of
availability of oral antibiotics for MRSA and reluc-
tance of residential or nursing homes to accept
MRSA positive patients.
(8) The results (mortality and amputation rates) for
the graft infection group, were combined, with
authors concluding that risk of death and/or
amputation was not related to the type of primary
operation. However, if one separates the figures
for mortality and amputation, there were 8/17
(50%) deaths in the aortic group compared to 9/
37 (25%) in the lower limb group. There were 2/17
(10%) amputations in the aortic group compared
with 16/37 (40%) in the lower limb group.
We believe that these differences are worthy of
comment.
The overall incidence of infection is not addressed by
this study but should be an important aspect of any
further multi-centre studies of this type. In particular
it would be important to determine whether the
MRSA is associated with an actual increase in the
number of vascular graft infections or just a change
in the microbiology and severity? Although it may be
true that MRSA is the commonest and most serious
cause of graft infection it is not possible to draw
these conclusions from the available data within this
audit.Eur J Vasc Endovasc Surg Vol 23, June 2002R. Beale, S. Homer-Vanniasinkam and
M. J. Gough
Leeds General Infirmary, U.K.
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Authors' Reply
Dr Beale raises a number of points regarding study
design, definitions, case heterogeneity and data inter-
pretation in the Joint Vascular Research Group (JVRG)
audit on complex wound and graft infection. In fact,
most of these had been anticipated by the authors
and were already conceded within the results and
discussion.
From the outset, the JVRG (rightly or wrongly) felt
that an anonymous audit was the best way of securing
participation from its members This was because
some surgeons did not wish their data to be available
to others. Inevitably, this decision precluded acqui-
sition of valuable demographic information and
prevented retrieval of missing data (organisms,
prophylactic antibiotics). I'm not convinced that the
inclusion of a control group would have manifestly
altered interpretation of the results. Apart from
Szylagi's definitions for type II and III infections, we
left `` diagnostic criteria'' for graft infection to the indi-
vidual surgeon. There is no consensus as to what
constitutes the best way of diagnosing infection, let
alone an accepted method for taking swabs! Type II
infections were retained (and differentiated) because
of interest in whether MRSA infection of the deep
subcutaneous tissues conferred an adverse outcome
(which they did). We accept that data interpretation
may have been confounded by the failure to always
document the responsible organism. However even if
some MRSAve patients were erroneously included
in the non-MRSA group, they would, actually, be
more likely to lessen the observed differences!
The JVRG audit (flaws apart) is the first to suggest
that MRSA is not only increasingly prevalent in vas-
cular practice but probably associated with a worse
outcome. Clearly, more rigorously designed, prospec-
tive studies are warranted and hopefully the JVRG
Correspondence 573will collaborate once again to address this issue. From
a practical point of view, multi-centre audits seem
simple in concept but are remarkably difficult to im-
plement in practice, despite repeated reminders to
members. The Leeds General Infirmary vascular sur-geons will, no doubt, have some sympathy with this
problem. They are, after all, members of the JVRG!
R. Naylor
Leicester, U.K.Eur J Vasc Endovasc Surg Vol 23, June 2002
